Vittorio Francavilla

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study.

Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study.

Journal: Frontiers in immunology

Published: December 16, 2025

Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly.

Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly.

Journal: Cancer research communications

Published: February 15, 2024

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART.

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART.

Journal: EBioMedicine

Published: January 14, 2021

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.

Journal: Frontiers in immunology

Published: October 31, 2018

"cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies".

"cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies".

Journal: Expert review of vaccines

Published: December 16, 2017

HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.

HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.

Journal: Retrovirology

Published: February 15, 2016

Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine.

Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine.

Journal: Expert opinion on biological therapy

Published: June 23, 2015

HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.

HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.

Journal: Retrovirology

Published: October 16, 2014

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study.

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study.

Journal: Retrovirology

Published: March 28, 2014

Immunologic biomarkers for clinical and therapeutic management of psoriasis.

Immunologic biomarkers for clinical and therapeutic management of psoriasis.

Journal: Mediators of inflammation

Published: March 06, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026